Exelixis (EXEL) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 02/11/20
Exelixis Reports Positive Results in Metastatic Castration-Resistant Prostate Cancer StudyThe Motley Fool • 02/11/20
Exelixis, Inc. (EXEL) Management presents at Piper Jaffray 31st Annual Healthcare Brokers Conference (Transcript)Seeking Alpha • 12/03/19
Exelixis, Inc. (EXEL) CEO Presents at Stifel Healthcare Brokers Conference (Transcript)Seeking Alpha • 11/19/19